Reviewed,
UniProtKB/Swiss-Prot P22725 (WNT5A_MOUSE)
Last modified
October 13, 2009.
Version 81.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein Wnt-5a | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 380 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Ligand for members of the frizzled family of seven transmembrane receptors. Can activate or inhibit canonical Wnt signaling, depending on receptor context. In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression. Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration. Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor. Mediates motility of melanoma cells. Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle. Inhibits type II collagen expression in chondrocytes. Ref.5 Ref.6 Ref.8 Ref.9 |
| Subunit structure | Interacts with PORCN. Ref.7 |
| Subcellular location | |
| Tissue specificity | Expressed in a gradient at the caudal end of the embryo during gastrulation and later in the distal-most aspect of several structures that extend from the body such as the limbs and genital tubercle. Ref.6 |
| Post-translational modification | Palmitoylation is necessary for stimulation of cell migration, inhibition of the beta-catenin pathway and receptor binding. Glycosylation is necessary for secretion but not for activity. |
| Disruption phenotype | Mice display perinatal lethality and display gross morphological defects in outgrowing tissues. They are truncated caudally, displaying loss of the tail and a significant shortening of the anterior-posterior axis. The shape of the head is abnormal with truncated snout, mandible and tongue and reduced outgrowth of the external ear. Fore- and hindlimbs lack digits, the genital tubercle is missing and chondrocyte differentiation is inhibited. Ref.6 Ref.8 |
| Sequence similarities | Belongs to the Wnt family. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P22725-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P22725-2) The sequence of this isoform differs from the canonical sequence as follows: 1-20: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 37 | 37 | Potential | ||||||
| Propeptide | 38 – 61 | 24 | PRO_0000352797 | ||||||
| Chain | 62 – 380 | 319 | Protein Wnt-5a | PRO_0000041428 | |||||
Amino acid modifications | |||||||||
| Lipidation | 104 | 1 | S-palmitoyl cysteine Ref.9 | ||||||
| Glycosylation | 114 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||
| Glycosylation | 120 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||
| Glycosylation | 312 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||
| Glycosylation | 326 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 20 | 20 | Missing in isoform 2. | VSP_035595 | |||||
Experimental info | |||||||||
| Mutagenesis | 104 | 1 | C → A: Abolishes palmitoylation. No effect on secretion. Ref.9 | ||||||
| Mutagenesis | 114 | 1 | N → Q: Abolishes glycosylation; when associated with Q-120, Q-312 and Q-326. Ref.9 | ||||||
| Mutagenesis | 120 | 1 | N → Q: Abolishes glycosylation; when associated with Q-114, Q-312 and Q-326. Ref.9 | ||||||
| Mutagenesis | 312 | 1 | N → Q: Abolishes glycosylation; when associated with Q-114, Q-120 and Q-326. Ref.9 | ||||||
| Mutagenesis | 326 | 1 | N → Q: Abolishes glycosylation; when associated with Q-114, Q-120 and Q-312. Ref.9 | ||||||
| Sequence conflict | 168 | 1 | Missing in AAA40567. Ref.1 | ||||||
| Sequence conflict | 190 – 191 | 2 | YR → HP in AAA40567. Ref.1 | ||||||
| Sequence conflict | 377 | 1 | F → L in BAC27430. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development." Gavin B.J., McMahon J.A., McMahon A.P. Genes Dev. 4:2319-2332(1990) [PubMed: 2279700] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Embryo. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Strain: C57BL/6J. Tissue: Testis and Vagina. |
| [3] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed: 19468303] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Mammary tumor. |
| [5] | "Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context." Mikels A.J., Nusse R. PLoS Biol. 4:E115-E115(2006) [PubMed: 16602827] [Abstract] Cited for: PROTEIN SEQUENCE OF 62-82, FUNCTION. |
| [6] | "A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo." Yamaguchi T.P., Bradley A., McMahon A.P., Jones S. Development 126:1211-1223(1999) [PubMed: 10021340] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE. |
| [7] | "The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family." Tanaka K., Okabayashi H., Asashima M., Perrimon N., Kadowaki T. Eur. J. Biochem. 267:4300-4311(2000) [PubMed: 10866835] [Abstract] Cited for: INTERACTION WITH PORCN. |
| [8] | "Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation." Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., Yang Y. J. Cell Biol. 162:899-908(2003) [PubMed: 12952940] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [9] | "Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling." Kurayoshi M., Yamamoto H., Izumi S., Kikuchi A. Biochem. J. 402:515-523(2007) [PubMed: 17117926] [Abstract] Cited for: FUNCTION, PALMITOYLATION AT CYS-104, GLYCOSYLATION AT ASN-114; ASN-120; ASN-312 AND ASN-326, MUTAGENESIS OF CYS-104; ASN-114; ASN-120; ASN-312 AND ASN-326. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| M89798 mRNA. Translation: AAA40567.1. AK031512 mRNA. Translation: BAC27430.1. AK031597 mRNA. Translation: BAC27468.1. AK036824 mRNA. Translation: BAC29593.1. CT025649 Genomic DNA. Translation: CAM27826.1. CT025649 Genomic DNA. Translation: CAM27827.1. BC018425 mRNA. Translation: AAH18425.1. | |
| IPI | IPI00410980. IPI00831451. |
| PIR | D36470. |
| RefSeq | NP_033550.2. |
| UniGene | Mm.287544 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P22725. 1 interaction. |
| STRING | P22725. |
Proteomic databases | |
| PRIDE | P22725. |
Genome annotation databases | |
| Ensembl | ENSMUST00000063465; ENSMUSP00000064878; ENSMUSG00000021994; Mus musculus. [Genome view] ENSMUST00000112274; ENSMUSP00000107893; ENSMUSG00000021994; Mus musculus. [Genome view] |
| GeneID | 22418. |
| KEGG | mmu:22418. |
| UCSC | uc007sug.1. mouse. |
Organism-specific databases | |
| CTD | 22418. |
| MGI | MGI:98958. Wnt5a. |
Phylogenomic databases | |
| HOVERGEN | P22725. |
Gene expression databases | |
| ArrayExpress | P22725. |
| Bgee | P22725. |
| CleanEx | MM_WNT5A. |
| Genevestigator | P22725. |
| GermOnline | ENSMUSG00000021994. Mus musculus. |
Family and domain databases | |
| InterPro | IPR005816. Wnt_grthfactor. IPR018161. Wnt_grthfactor_CS. [Graphical view] |
| PRINTS | PR01349. WNTPROTEIN. |
| PROSITE | PS00246. WNT1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| SOURCE | Search... |
Entry information
| Entry name | WNT5A_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P22725 Secondary accession number(s): Q8BM17, Q8BMF9, Q8VCV6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


